Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
Is it reasonable to use hypofractionation in breast cancer patients with non-active connective tissue disorders?
Answer from: Radiation Oncologist at Academic Institution
Yes, it is reasonable to use hypofractionation in this patient panel. I have used the Canadian fractionation schedule several times in this scenario.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
I’ve also routinely done this with no issue at all.
Sign in or Register to read more
15771
15793
Related Questions
Are there any potential benefits to irradiating the partial breast with an MR-linac over conventional linac?
Is it acceptable to give hypofractionated breast radiation in a patient who is being treated for rheumatoid arthritis with Actemra, methotrexate and leucovorin?
What criteria do you use to determine the utility of DIBH for breast cancer patients?
What do you do when the dose constraints for heart and/or lung do not pass at all in a whole breast treatment planning?
Would you cover regional nodes in an early-stage breast cancer with a non-mapping sentinel lymph node?
Would you consider PBI plus covering the regional lymph nodes for a LN+ breast cancer in the remnant of the axillary tail?
What dose and fractionation regimen would you use for a patient with DCIS with multiple close margins unable to undergo re-excision, who has a history of photosensitivity (polymorphous light eruption)?
Do you ever treat a recurrent breast cancer with RNI alone rather than chest wall and RNI?
Would you consider a FAST-forward fractionation for a cT1a IDC with DCIS that was found to be pTis on lumpectomy specimen?
Would you have a patient temporarily discontinue methotrexate while receiving a FAST or FAST FORWARD regimen for breast irradiation?